Aurobindo Pharma's expenditure on R&D FY 2017-2022, by type
In fiscal year 2022, Aurobindo Pharma spent around 0.31 billion Indian rupees on capital expenses for research and development of pharmaceutical drugs. Recurring expenses for R&D of the company were more than 8.66 billion rupees in the same year.